Louise Cummings

The Oxford Handbook of Communication Disorders in Neurodegenerative Diseases

• Gebundenes Buch

Produktbeschreibung

This handbook provides a synthesis of current communication disorders research in patients with a range of neurodegenerative conditions. It brings together research and clinical practice to offer a comprehensive understanding of the impact of neurogenerative processes on communication.

Produktdetails

• Verlag: Oxford University Press
• Seitenzahl: 528
• Erscheinungstermin: 1. März 2026
• Englisch
• Abmessung: 253mm x 180mm x 33mm
• Gewicht: 1166g
• ISBN-13: 9780198888482
• ISBN-10: 0198888481
• Artikelnr.: 74543770

Autorenporträt

Louise Cummings is Professor in the Department of English and Communication and Associate Dean in the Graduate School at The Hong Kong Polytechnic University. She conducts research in pragmatics, clinical linguistics, communication disorders, and public health reasoning. She is the author and editor of over 20 books, including most recently COVID-19 and Speech-Language Pathology (Routledge, 2023) and Language in Dementia (Cambridge University Press, 2020); she is also editor of the book series Routledge Research in Speech-Language Pathology and Cambridge Elements in Health Communication. She is a member of the Royal College of Speech and Language Therapists and the Health & Care Professions Council in the UK.

Inhaltsangabe

* 1: Kimberly D. Mueller: Communication Disorders in neurodegenerative
disease: State of the art
* Part I. Speech, voice, hearing, and fluency disorders in
neurodegenerative diseases
* 2: Ellika Schalling: Dysarthria and dysphonia in Parkinson's disease
* 3: Lynda Feenaughty: Dysarthria in multiple sclerosis
* 4: Panying Rong and Lindsey B. Heidrick: Dysarthria in amyotrophic
lateral sclerosis
* 5: Michael de Riesthal and Sarah K. Diehl: Dysarthria in Huntington's
disease
* 6: Allison Hilger: Dysarthria in cerebellar ataxia
* 7: Karen Croot, Lisa Wauters, and Anja Staiger: Apraxia of speech in
primary progressive aphasia and primary progressive apraxia of speech
* 8: Heather M. Clark: Apraxia of speech and dysarthria in progressive
supranuclear palsy
* 9: Kathleen Scaler Scott: Stuttering and cluttering in
neurodegenerative disorders
* 10: Nick Miller and Fiona Stewart: Foreign accent syndrome in
neurodegenerative disorders
* 11: Dale Sharrad, Anthipa Chokesuwattansakul, Benjamin Levett, Anna
Volkmer, Chris J. D. Hardy, and Jason D. Warren: Hearing impairment
in neurodegenerative disorders
* Part II. Language disorders in neurodegenerative diseases
* 12: Aurélie Pistono, Thi Mai Tran, and Laurent Lefebvre: Language in
Alzheimer's disease
* 13: Anahita Basirat: Language in Parkinson's disease
* 14: Charlotta Saldert: Language in Huntington's disease
* 15: Sara Nordio, Maria Zampieri, Valentina Bambini, and Giorgio
Arcara: Language in multiple sclerosis
* 16: Joël Macoir, Monica Lavoie, and Guillaume Duboisdindien: Language
in primary progressive aphasia
* 17: Amandine Géraudie and Maxime Montembeault: Language in behavioral
variant frontotemporal dementia
* 18: Isabel Junqueira de Almeida, Maria Teresa Carthery-Goulart, and
Jacy Bezerra Parmera: Language in corticobasal syndrome
* 19: Louise Cummings: Language in COVID-19
* 20: Nishant K. Mishra, Shubham Misra, and Jean-Marie Annoni: Language
in bilingual speakers with neurodegenerative disease
* Part III. Clinical management of neurodegenerative communication
disorders
* 21: Laura L. Murray and Eun Jin Paek: Approaches to communication
assessment in adults with neurodegenerative disorders
* 22: Allison Chen, Marie Y. Savundranayagam, and Angela Roberts:
Approaches to communication intervention in adults with
neurodegenerative diseases
* 23: Angela Roberts, Olivia Fegter, J. B. Orange, and Emily Rogalski:
Measuring outcomes of communication intervention in adults with
neurodegenerative disorders
* 24: Jean Neils-Strunjas and Nidhi Mahendra: Application of strategies
for prevention of cognitive decline in the speech-language
pathologist's practice
* 25: Elise Roger and Yves Joanette: Communication disorders in
neurodegenerative disease: Future directions